Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.3100
-0.0119 (-3.70%)
At close: Jun 18, 2025, 4:00 PM
0.3101
+0.0001 (0.03%)
After-hours: Jun 18, 2025, 7:52 PM EDT
Athira Pharma Stock Forecast
ATHA's stock price has decreased by -88.08% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover Athira Pharma stock have a consensus rating of "Buy" and an average price target of $11.25, which forecasts a 3529.03% increase in the stock price over the next year. The lowest target is $0.5 and the highest is $22.
Price Target: $11.25 (+3529.03%)
Analyst Consensus: Buy
* Price targets were last updated on Sep 19, 2024.
Analyst Ratings
The average analyst rating for Athira Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy → Hold Downgrades $5 → $0.5 | Buy → Hold | Downgrades | $5 → $0.5 | +61.29% | Sep 19, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
| BTIG | BTIG | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 4, 2024 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +6,996.77% | Aug 19, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $19 | Buy | Reiterates | $19 | +6,029.03% | Jun 20, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.76
from -2.52
EPS Next Year
-1.08
from -0.76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.77 | -1.11 | -0.81 |
| Avg | -0.76 | -1.08 | -0.79 |
| Low | -0.74 | -1.04 | -0.75 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.